TGTX- Tg Therapeutics, Inc.

Across the last three months, Tg Therapeutics, Inc.'s insiders have reduced their positions by a net 5,000 shares worth roughly $275K.

Classified under Biotechnology (Health Care sector), TGTX's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Weiss Michael S	9.78M	-	-
CFO	Power Sean A	798.1K	-	-
Dir	Charney Laurence N	168.6K	$9.27M	-
Dir	Hoberman Kenneth	8.3K	-	-
Dir	Echelard Yann	8.3K	-	-

Buys and sells only

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Dec 10, 2020	Echelard Yann49	Director	Sell	30,000	$40.05	$1,201,500.00	-18.9%
Sep 9, 2020	Ra Capital Management, L.P.52	10% Owner	Sell	158,589	$25.81	$4,092,738.04	-1.2%
Jun 17, 2020	Kennedy William James	Director	Sell	7,745	$18.27	$141,501.15	-7.6%
Jul 1, 2019	Power Sean A60	CFO, Secretary And Treasurer	Sell	17,654	$8.47	$149,529.38	-4.4%
Jun 26, 2019	Weiss Michael S63	CEO And President	Buy	50,000	$7.04	$351,750.00	+0.4%
Jan 2, 2019	Power Sean A60	CFO, Secretary And Treasurer	Sell	37,275	$4.13	$153,945.75	-8.5%
Jul 3, 2018	Power Sean A60	CFO, Secretary And Treasurer	Sell	47,191	$13.21	$623,302.66	-9.7%
Jun 14, 2018	Kennedy William James	Director	Sell	25,071	$13.45	$337,204.95	-29.4%
Jan 2, 2018	Power Sean A60	CFO, Secretary And Treasurer	Sell	32,006	$8.50	$272,051.00	-6.2%
Jun 19, 2017	Power Sean A60	CFO, Secretary And Treasurer	Sell	59,976	$11.09	$665,132.64	-11.8%